Incidence and course of acute coronary syndromes cases following first wave of COVID-19 pandemy
| Autor: | K Sanetra, M Kutowicz, Piotr P. Buszman, J Jankowska Sanetra, M Konopko, M Synak, Krzysztof Milewski, M Kachel, P E Kazmierczak |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) business.industry Incidence (epidemiology) Coronary arteriosclerosis Time to treatment medicine.disease Abstract Supplement Epidemiology Prognosis Outcome Internal medicine Diabetes mellitus Epidemiology Hyperlipidemia medicine AcademicSubjects/MED00200 Cardiology and Cardiovascular Medicine business |
| Zdroj: | European Heart Journal Europe PubMed Central |
| ISSN: | 1522-9645 0195-668X |
| Popis: | Background SARS-COV-2 virus pandemic is a challenge for healthcare across the globe. Although COVID-19 is a significant cause of mortality and morbidity, the collateral damage caused by this disease might influence patients with cardiovascular disease, especially acute coronary syndromes (ACS) very prone to treatment delay and lack of infrastructure and staff availability. Additionally lock-down causes patients concern and reluctance which further delays the invasive. treatment. Purpose In our report we sought to analyse the incidence and course of ACS patients following the first wave of COVID-19 pandemy in Poland. Methods The report represents multiinstitutional registry, with 10 interventional cardiology departments included. The data was gathered from a timeframe separating two waves of the pandemy (June-October), which reflects the situation directly following the first lockdown in Poland (30 March- 31 May 2020) and limitations in planned medical care. The data was compared to same timeframe in year 2019. Patients who were admitted with ACS were included. In hospital outcome was analyzed. Results There were 2801 patients hospitalized for acute coronary syndrome in 2019 (Jun-Oct) and 2620 in 2020 (Jun-Oct), which is respectively 52.8% and 57.9% of coronary artery disease admissions (p Conclusions The COVID-19 pandemic affects both ACS patient profile and course of treatment, which became apparent already after first wave of pandemic. Patient admitted after lockdown has more risk factors, there was a trend toward higher mortality and patient presented more often with acute heart failure, more likely due to delay in treatment or no invasive treatment for MI. Funding Acknowledgement Type of funding sources: None. Patients baseline characteristicsHospitalization outcomes |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|